An Australian man has become the first person in the world to leave hospital with an artificial heart made of titanium, known as BiVACOR. This device is used as a temporary measure for people with heart failure who are waiting for a donor heart. The man lived with the device for over three months before undergoing surgery to receive a donated human heart. This breakthrough has significant implications for the treatment of heart failure patients and may lead to the development of permanent artificial heart options in the future.
Forecast for 6 months: Expect increased interest and investment in artificial heart technology, with several medical institutions and companies exploring the development of similar devices. Regulatory bodies may also begin to review and approve new artificial heart devices for clinical use.
Forecast for 1 year: BiVACOR and similar artificial heart devices may become more widely available for clinical use, with several hospitals and medical centers incorporating them into their treatment protocols. Researchers may also begin to publish more studies on the long-term efficacy and safety of these devices.
Forecast for 5 years: Artificial heart technology may become a standard treatment option for heart failure patients, with several companies developing and marketing their own versions of the device. The cost of these devices may decrease, making them more accessible to patients worldwide.
Forecast for 10 years: Artificial hearts may become a permanent solution for heart failure patients, with several companies developing implantable devices that can be powered by the body’s own energy. The development of artificial hearts may also lead to breakthroughs in other areas of medical technology, such as prosthetics and organ transplantation.
